Search - tctmd.com

Displaying 601 - 620 of 900

Sort: Relevancy | Date

Presentation PCI Outcomes 2014

Antiplatelet Therapy Before, During, and After PCI: Which One and How Long?

Presenter: Dominick J. Angiolillo

March 28, 2014

Presentation PCI Outcomes 2014

Atrial Fibrillation and PCI: Antiplatelet Therapy Recommendations

Presenter: Christopher Granger

March 28, 2014

Presentation

Risk of Stroke in Patients with High On-Clopidogrel Platelet Reactivity to Adenosine Diphosphate after PCI

Presenter: Nevio Taglieri

March 25, 2014

Presentation

Meta-analysis of Time-Related Benefits of Statin Therapy in Patients with ACS Undergoing PCI

Presenter: Eliano Pio Navarese

March 10, 2014

Presentation

INFUSE-AMI: Outcomes in Patients with STEMI Treated with Clopidogrel vs Prasugrel

Presenter: Sorin J. Brener

February 26, 2014

Presentation

Impact of Major Bleeding on Long-term Mortality in Anemic Patients Undergoing PCI Using Bivalirudin

Presenter: Ziad A. Ali

February 25, 2014

Presentation

Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients

Presenter: Paul Dorian

February 20, 2014

Presentation

Lack of Association Between DAPT Use and Stent Thrombosis Between 1 and 12 Months Following Resolute ZES Implantation

Presenter: 115704|Sigmund Silber

February 17, 2014

Presentation

Early Post-discharge Bleeding and Antiplatelet Discontinuation in AMI Patients Treated with PCI

Presenter: 222318|Tracy Wang

February 03, 2014

Presentation

Optimizing P2Y12-Receptor Inhibition in ACS Patients Based on Platelet Function Testing

Presenter: 228579|Daniel Aradi

January 29, 2014

Presentation

Loading Dose Has No Additive Effect on Platelet Aggregation During the Switch from Ongoing Clopidogrel to Ticagrelor in ACS Patients

Presenter: G. Caiazzo

January 28, 2014

Presentation

Meta-analysis of Randomized Controlled Trials on the Risk of Bleeding with Dabigatran

Presenter: B.J. Bloom

January 06, 2014

Presentation

Transport to Primary PCI vs. On-site Fibrinolysis Is Independent Predictor of Functional Status after MI

Presenter: D.M. Bilkova

December 16, 2013

Presentation

Preoperative Statins and Limb Salvage after Lower Extremity Revascularization in the Medicare Population

Presenter: Todd R. Vogel

December 11, 2013

Presentation

Impact of Worsening Renal Dysfunction on the Comparative Efficacy of Bivalirudin and Platelet GPIs

Presenter: E. Perdoncin

December 10, 2013

Presentation

Effect of Remote Ischemic Preconditioning (IPC) on Platelet Activation and Reactivity Induced by Ablation for A-Fib

Presenter: A. Stazi

December 09, 2013

Presentation

Is Gender a Risk Factor? Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI): Results from the Real-World PARIS Reg

Presenter: Roxana Mehran

December 01, 2013

Presentation

Combining Anticoagulant and Antiplatelet Treatment in Patients with Atrial Fibrillation Undergoing PCI - How to Minimize Bleeding and Ischemic Risks?

Presenter: Eli Lev

December 01, 2013

Presentation

Clinical outcomes associated with dual antiplatelet therapy interruption following implantation of the ResoluteTM zotarolimus-eluting stent

Presenter: Martin T. Rothman

December 01, 2013

Presentation

A Randomised Controlled Trial of Platelet Activity Before and After Cessation of Clopidogrel in Patients with Stable Cardiovascular Disease

Presenter: Isobel Ford

November 12, 2013

Advertisement

Antiplatelet Therapy Before, During, and After PCI: Which One and How Long?

Atrial Fibrillation and PCI: Antiplatelet Therapy Recommendations

Risk of Stroke in Patients with High On-Clopidogrel Platelet Reactivity to Adenosine Diphosphate after PCI

Meta-analysis of Time-Related Benefits of Statin Therapy in Patients with ACS Undergoing PCI

INFUSE-AMI: Outcomes in Patients with STEMI Treated with Clopidogrel vs Prasugrel

Impact of Major Bleeding on Long-term Mortality in Anemic Patients Undergoing PCI Using Bivalirudin

Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients

Lack of Association Between DAPT Use and Stent Thrombosis Between 1 and 12 Months Following Resolute ZES Implantation

Early Post-discharge Bleeding and Antiplatelet Discontinuation in AMI Patients Treated with PCI

Optimizing P2Y12-Receptor Inhibition in ACS Patients Based on Platelet Function Testing

Loading Dose Has No Additive Effect on Platelet Aggregation During the Switch from Ongoing Clopidogrel to Ticagrelor in ACS Patients

Meta-analysis of Randomized Controlled Trials on the Risk of Bleeding with Dabigatran

Transport to Primary PCI vs. On-site Fibrinolysis Is Independent Predictor of Functional Status after MI

Preoperative Statins and Limb Salvage after Lower Extremity Revascularization in the Medicare Population

Impact of Worsening Renal Dysfunction on the Comparative Efficacy of Bivalirudin and Platelet GPIs

Effect of Remote Ischemic Preconditioning (IPC) on Platelet Activation and Reactivity Induced by Ablation for A-Fib

Is Gender a Risk Factor? Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI): Results from the Real-World PARIS Reg

Combining Anticoagulant and Antiplatelet Treatment in Patients with Atrial Fibrillation Undergoing PCI - How to Minimize Bleeding and Ischemic Risks?

Clinical outcomes associated with dual antiplatelet therapy interruption following implantation of the ResoluteTM zotarolimus-eluting stent

A Randomised Controlled Trial of Platelet Activity Before and After Cessation of Clopidogrel in Patients with Stable Cardiovascular Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content